Carolyn Orr

1.9k total citations
28 papers, 1.4k citations indexed

About

Carolyn Orr is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Carolyn Orr has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Neurology. Recurrent topics in Carolyn Orr's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Neurological diseases and metabolism (2 papers). Carolyn Orr is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Neurological diseases and metabolism (2 papers). Carolyn Orr collaborates with scholars based in Australia, United States and United Kingdom. Carolyn Orr's co-authors include Dominic B. Rowe, Glenda M. Halliday, Yoshikuni Mizuno, Hideo Mori, J. Eric Ahlskog, Joseph E. Parisi, Dennis W. Dickson, Roberta Frigerio, Anthony DelleDonne and Kevin J. Klos and has published in prestigious journals such as Brain, Neurology and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Carolyn Orr

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolyn Orr Australia 14 707 502 356 281 270 28 1.4k
D Caparros-Lefèbvre France 23 1.0k 1.4× 242 0.5× 503 1.4× 714 2.5× 183 0.7× 58 2.2k
Tomohiko Mizutani Japan 22 761 1.1× 230 0.5× 247 0.7× 272 1.0× 405 1.5× 87 1.7k
Sandro Dá Mesquita United States 15 341 0.5× 557 1.1× 472 1.3× 297 1.1× 299 1.1× 25 1.5k
Hayrettin Tumani Germany 21 626 0.9× 257 0.5× 163 0.5× 424 1.5× 386 1.4× 42 1.6k
Z Stelmasiak Poland 21 519 0.7× 155 0.3× 241 0.7× 102 0.4× 201 0.7× 88 1.5k
P. C. Blumbergs Australia 18 655 0.9× 164 0.3× 316 0.9× 181 0.6× 215 0.8× 41 1.3k
C H Hawkes United Kingdom 18 944 1.3× 287 0.6× 320 0.9× 189 0.7× 281 1.0× 30 1.7k
Emma Thornton Australia 19 387 0.5× 157 0.3× 245 0.7× 270 1.0× 351 1.3× 33 1.2k
F Gray France 16 698 1.0× 316 0.6× 367 1.0× 253 0.9× 203 0.8× 53 1.4k
H.‐M. Meinck Germany 24 593 0.8× 213 0.4× 491 1.4× 153 0.5× 308 1.1× 65 1.6k

Countries citing papers authored by Carolyn Orr

Since Specialization
Citations

This map shows the geographic impact of Carolyn Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn Orr more than expected).

Fields of papers citing papers by Carolyn Orr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn Orr. The network helps show where Carolyn Orr may publish in the future.

Co-authorship network of co-authors of Carolyn Orr

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn Orr. A scholar is included among the top collaborators of Carolyn Orr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn Orr. Carolyn Orr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Melanie L., et al.. (2023). A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington’s disease. Neuroscience & Biobehavioral Reviews. 149. 105166–105166. 6 indexed citations
2.
Lam, Virginie, Roger Clarnette, Roslyn J. Francis, et al.. (2022). Efficacy of probucol on cognitive function in Alzheimer’s disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study). BMJ Open. 12(2). e058826–e058826. 7 indexed citations
3.
4.
Orr, Carolyn, et al.. (2019). 063 Headache with periorbital ecchymosis; a rare clinical entity. Journal of Neurology Neurosurgery & Psychiatry. 90(e7). A20.3–A21. 2 indexed citations
5.
Golzan, Mojtaba, Kathryn Goozee, Dana Georgevsky, et al.. (2017). Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer’s disease. Alzheimer s Research & Therapy. 9(1). 13–13. 83 indexed citations
6.
Evans, James, et al.. (2014). Novel finding of carbamazepine induced gall bladder granulomatous vasculitis. Internal Medicine Journal. 44(7). 700–703. 4 indexed citations
7.
Ramanathan, Sudarshini, Andrew Bleasel, Nevin John, et al.. (2013). Characterisation of a syndrome of autoimmune adult onset focal epilepsy and encephalitis. Journal of Clinical Neuroscience. 21(7). 1169–1175. 12 indexed citations
8.
Blair, Nicholas, Carolyn Orr, Anthony Delaney, & Geoffrey Herkes. (2013). Angiostrongylus meningoencephalitis: survival from minimally conscious state to rehabilitation. The Medical Journal of Australia. 198(8). 440–442. 20 indexed citations
9.
Boot, Brendon, Carolyn Orr, J. Eric Ahlskog, et al.. (2013). Risk factors for dementia with Lewy bodies. Neurology. 81(9). 833–840. 119 indexed citations
10.
Stevens, Claire H., Dominic B. Rowe, Marie‐Christine Morel‐Kopp, et al.. (2012). Reduced T helper and B lymphocytes in Parkinson's disease. Journal of Neuroimmunology. 252(1-2). 95–99. 149 indexed citations
11.
Boot, B., Carolyn Orr, Tanis J. Ferman, et al.. (2012). Risk Factors for Dementia with Lewy Bodies (S24.005). Neurology. 78(Meeting Abstracts 1). S24.005–S24.005. 1 indexed citations
12.
Boeve, Bradley F., Brendon Boot, Carolyn Orr, et al.. (2011). Clinical Characterization of a Kindred With a Novel 12-Octapeptide Repeat Insertion in the Prion Protein Gene. Archives of Neurology. 68(9). 1165–1165. 21 indexed citations
13.
Dickson, Dennis W., Hiroshige Fujishiro, Carolyn Orr, et al.. (2009). Neuropathology of non-motor features of Parkinson disease. Parkinsonism & Related Disorders. 15. S1–S5. 204 indexed citations
14.
Dickson, Dennis W., Carolyn Orr, Anthony DelleDonne, et al.. (2009). O.014 Neuropathology of non-motor features of Parkinson disease. Parkinsonism & Related Disorders. 15. S5–S5. 4 indexed citations
15.
Orr, Carolyn & J. Eric Ahlskog. (2009). Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity. Archives of Neurology. 66(7). 54 indexed citations
16.
Orr, Carolyn, Dominic B. Rowe, Yoshikuni Mizuno, Hideo Mori, & Glenda M. Halliday. (2005). A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain. 128(11). 2665–2674. 295 indexed citations
17.
Orr, Carolyn, Dominic B. Rowe, & Glenda M. Halliday. (2004). Immune-inflammatory changes in the substantia nigra in Parkinson's disease. Movement Disorders. 19. 347–347.
18.
Orr, Carolyn & Catherine E. Storey. (2004). Recurrent Miller–Fisher syndrome. Journal of Clinical Neuroscience. 11(3). 307–309. 17 indexed citations
19.
Orr, Carolyn & Dominic B. Rowe. (2003). Eardrop attacks: seizures triggered by ciprofloxacin eardrops. The Medical Journal of Australia. 178(7). 343–343. 3 indexed citations
20.
Orr, Carolyn, Dominic B. Rowe, & Glenda M. Halliday. (2002). An inflammatory review of Parkinson’s disease. Progress in Neurobiology. 68(5). 325–340. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Caparros-Lefèbvre Breakdown of academic impact, for papers by Tomohiko Mizutani Breakdown of academic impact, for papers by Sandro Dá Mesquita Breakdown of academic impact, for papers by Hayrettin Tumani Breakdown of academic impact, for papers by Z Stelmasiak Breakdown of academic impact, for papers by P. C. Blumbergs Breakdown of academic impact, for papers by C H Hawkes Breakdown of academic impact, for papers by Emma Thornton Breakdown of academic impact, for papers by F Gray Breakdown of academic impact, for papers by H.‐M. Meinck
Rankless by CCL
2026